# An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

> **NCT03674476** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 40 (actual)

## Conditions studied

- NAFLD
- Nonalcoholic Fatty Liver Disease
- Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** BMS-986036

## Key facts

- **NCT ID:** NCT03674476
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-11
- **Primary completion:** 2019-06-24
- **Final completion:** 2019-06-24
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03674476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03674476, "An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03674476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*